WSJ News Exclusive | Merck moves forward with potential deal for Seasonale

According to people familiar with the matter, Merck & Co. is moving forward with a potential deal for biotech Seagen Inc., which will be one of the biggest acquisitions of the year.

wall street journal reported last week That Merck was in talks to buy Cezanne, which would bolster the pharmaceutical giant’s cancer-drug portfolio, but no agreement was imminent. Some said on Thursday that talks had picked up pace and the two companies were due to meet this week.